The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
An innovative and fast-growing digital healthtech company based in Southern Italy is transforming the pharmaceutical retail sector through intelligent software and integrated logistics. The company offers a proprietary, cloud-based platform that leverages AI and cutting-edge technology to optimize pharmacy operations, ensure drug traceability, and enhance therapeutic continuity—especially for vulnerable patient populations.
The firm operates a hybrid business model combining owned physical pharmacies, a modern pharmaceutical e-commerce platform, and a state-of-the-art logistics hub. Its vision is to build a fully digitized, highly efficient healthcare goods and services supply chain.
Investor Benefits
Tax Incentives: Recognized as an “innovative startup,” enabling investors to claim up to 30% of invested capital as a tax credit.
Low-Risk Profile: Active operations with strong execution track record.
High Market Potential: Addressing growing demand for digitized, efficient pharmacy services in Italy’s evolving healthcare landscape.
Investment Opportunity
The company is seeking €800K to accelerate its strategic expansion, including:
Acquiring 3 additional pharmacies to strengthen regional footprint.
Expanding warehouse capacity and integrating statistical tools to prevent medicine shortages.
Patent development for software integrated with national healthcare systems.
Enhancing the digital customer experience via a revamped web presence and internal process optimization.
Financial Snapshot (€‘000)
2022 Revenue: €2.5M
2023 Revenue: €3.5M
2024 Revenue: €4.5M
2025E Revenue: €5.0M
Steady EBITDA growth with improving margins projected.
An innovative and fast-growing digital healthtech company based in Southern Italy is transforming the pharmaceutical retail sector through intelligent software and integrated logistics. The company offers a proprietary, cloud-based platform that leverages AI and cutting-edge technology to optimize pharmacy operations, ensure drug traceability, and enhance therapeutic continuity—especially for vulnerable patient populations.
The firm operates a hybrid business model combining owned physical pharmacies, a modern pharmaceutical e-commerce platform, and a state-of-the-art logistics hub. Its vision is to build a fully digitized, highly efficient healthcare goods and services supply chain.
Investor Benefits
Tax Incentives: Recognized as an “innovative startup,” enabling investors to claim up to 30% of invested capital as a tax credit.
Low-Risk Profile: Active operations with strong execution track record.
High Market Potential: Addressing growing demand for digitized, efficient pharmacy services in Italy’s evolving healthcare landscape.
Investment Opportunity
The company is seeking €800K to accelerate its strategic expansion, including:
Acquiring 3 additional pharmacies to strengthen regional footprint.
Expanding warehouse capacity and integrating statistical tools to prevent medicine shortages.
Patent development for software integrated with national healthcare systems.
Enhancing the digital customer experience via a revamped web presence and internal process optimization.
Financial Snapshot (€‘000)
2022 Revenue: €2.5M
2023 Revenue: €3.5M
2024 Revenue: €4.5M
2025E Revenue: €5.0M
Steady EBITDA growth with improving margins projected.
Description
An innovative and fast-growing digital healthtech company based in Southern Italy is transforming the pharmaceutical retail sector through intelligent software and integrated logistics. The company offers a proprietary, cloud-based platform that leverages AI and cutting-edge technology to optimize pharmacy operations, ensure drug traceability, and enhance therapeutic continuity—especially for vulnerable patient populations.
The firm operates a hybrid business model combining owned physical pharmacies, a modern pharmaceutical e-commerce platform, and a state-of-the-art logistics hub. Its vision is to build a fully digitized, highly efficient healthcare goods and services supply chain.
Investor Benefits
Tax Incentives: Recognized as an “innovative startup,” enabling investors to claim up to 30% of invested capital as a tax credit.
Low-Risk Profile: Active operations with strong execution track record.
High Market Potential: Addressing growing demand for digitized, efficient pharmacy services in Italy’s evolving healthcare landscape.
Investment Opportunity
The company is seeking €800K to accelerate its strategic expansion, including:
Acquiring 3 additional pharmacies to strengthen regional footprint.
Expanding warehouse capacity and integrating statistical tools to prevent medicine shortages.
Patent development for software integrated with national healthcare systems.
Enhancing the digital customer experience via a revamped web presence and internal process optimization.
Financial Snapshot (€‘000)
2022 Revenue: €2.5M
2023 Revenue: €3.5M
2024 Revenue: €4.5M
2025E Revenue: €5.0M
Steady EBITDA growth with improving margins projected.
Investment Size: 800,000 EUR
Basic Details
Target Price:
TBD
Business ID:
L#20250942
Country
Italy
Detail
PREVIOUS PROPERTY
Leading Industrial Robotics Company
NEXT PROPERTY
Italian Cosmetic Skincare Business